Cha Eunseok, Erlen Judith A, Kim Kevin H, Sereika Susan M, Caruthers Donna
Chung-Ang University, Department of Nursing School of Medicine, Seoul 156-756, South Korea.
Int J Nurs Stud. 2008 Aug;45(8):1175-84. doi: 10.1016/j.ijnurstu.2007.08.003. Epub 2007 Oct 22.
To date, only a few studies have examined the mediating role of self-efficacy on the relationship between depressive symptoms or perceived social support and medication adherence in persons with HIV.
The purpose of this study was to examine the impact of perceived social support, depressive symptoms and medication-taking self-efficacy on self-reported medication adherence in persons with HIV. A proposed comprehensive model included three mediation hypotheses in order to examine the mediating roles of medication-taking self-efficacy and depressive symptoms.
Baseline data from "Adherence to Protease Inhibitors" were used. The 215 persons with HIV aged 19-61 (mean=40.7, S.D.=7.58) were recruited from multiple sites in Pittsburgh, PA (USA) and through self-referral. The participants were assessed using the Beck Depression Inventory, Interpersonal Support Evaluation List, the Medication Taking Self-Efficacy Scale, and the modified Morisky Self-report Medication Taking Scale. Structural equation modeling (EQS version 6.1) was used. The Satorra-Bentler Scaled chi(2) test statistics (S-B chi(2)), Comparative Fit Index (CFI), and the Standardized Root Mean Squared Residual (SRMR) were used to assess the fit of a comprehensive model including three mediation hypotheses.
A comprehensive model with the three hypotheses showed a good model fit (S-B chi(2) (24, N=215)=69.06, p<.001; CFI=.95; SRMR=.057). Medication adherence self-efficacy fully mediated the prediction of self-reported medication adherence by perceived social support and depressive symptoms. Depressive symptoms partially mediated the prediction of medication-taking self-efficacy by perceived social support.
The findings of this study provide researchers with increased understanding of the mediating role of medication-taking self-efficacy beliefs between selected psychological variables and self-reported medication adherence in persons with HIV. Future studies need to test the moderating effect of gender, ethnicity and risk factors for HIV on this model and the intervention effect of self-efficacy beliefs using longitudinal data.
迄今为止,仅有少数研究探讨了自我效能感在艾滋病毒感染者的抑郁症状或感知到的社会支持与药物依从性之间关系中的中介作用。
本研究旨在探讨感知到的社会支持、抑郁症状和服药自我效能感对艾滋病毒感染者自我报告的药物依从性的影响。一个提出的综合模型包含三个中介假设,以检验服药自我效能感和抑郁症状的中介作用。
使用“蛋白酶抑制剂依从性”研究的基线数据。从美国宾夕法尼亚州匹兹堡的多个地点通过自我推荐招募了215名年龄在19 - 61岁(平均 = 40.7,标准差 = 7.58)的艾滋病毒感染者。使用贝克抑郁量表、人际支持评估清单、服药自我效能量表和改良的莫里isky自我报告服药量表对参与者进行评估。采用结构方程模型(EQS 6.1版)。使用萨托拉 - 本特勒标度卡方检验统计量(S - B卡方)、比较拟合指数(CFI)和标准化根均方残差(SRMR)来评估包含三个中介假设的综合模型的拟合度。
包含这三个假设的综合模型显示出良好的模型拟合度(S - B卡方(24, N = 215) = 69.06,p <.001;CFI =.95;SRMR =.057)。服药依从性自我效能感完全中介了感知到的社会支持和抑郁症状对自我报告的药物依从性的预测。抑郁症状部分中介了感知到的社会支持对服药自我效能感的预测。
本研究结果使研究人员对服药自我效能感信念在艾滋病毒感染者特定心理变量与自我报告的药物依从性之间的中介作用有了更多了解。未来的研究需要使用纵向数据来检验性别、种族和艾滋病毒风险因素对该模型的调节作用以及自我效能感信念的干预效果。